// App-Quantinova.ai

e21597 : Intravenous ferric carboxymaltose treatment in cancer patients.

Researchers

Presenter

  • Alma Aslan

Principal Investigators

  • Vildan Tasdemir

  • Neyran Kertmen

  • Omer Dizdar

  • Sercan Aksoy

Medical Centers

  • Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Solid malignancies

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • Ferric carboxymaltose

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved